CD8A and Epstein-Barr virus infection: These results indicate that the hCD8+ T cells are getting activated by human B cells following EBV infection in a dose-dependent manner, and a small part of hCD8+hCD69+hCD137+ T cells are EBV-specific CD8+ T cells.